Updated May 16, 2026 · 798 articles
Learn
Educational guides about 13F filings, insider trading, institutional investing, and how to track smart money moves.
Networking Equipment 13Fs: Cisco, Arista, Juniper, F5 Decoder
Cisco Systems, Arista Networks, Juniper Networks (pending HPE acquisition), F5 Networks, and Extreme Networks anchor US networking equipment 13F positioning. AI back-end networking, campus refresh cycles, plus emerging software-defined transitions drive distinctive institutional patterns.
Enterprise Storage 13Fs: NetApp, Pure Storage, Nutanix Decoder
NetApp, Pure Storage, Nutanix, plus emerging hybrid cloud storage operators anchor US-traded enterprise storage 13F positioning. All-flash array adoption, hybrid cloud integration, AI training data infrastructure, and emerging subscription model dynamics drive distinctive institutional patterns.
AI Server 13Fs: Dell, Super Micro, HPE, Arista Decoder
Dell Technologies, Super Micro Computer, Hewlett Packard Enterprise, Arista Networks, and Lenovo anchor US-traded AI server 13F positioning. Hyperscaler AI capex cycles, NVIDIA GPU allocation dynamics, liquid cooling integration, and AI inference deployment drive distinctive institutional patterns.
Discrete Semi 13Fs: ON, Microchip, Skyworks, Qorvo Decoder
ON Semiconductor, Microchip Technology, Skyworks Solutions, Qorvo, and NXP Semiconductors anchor US-traded analog plus discrete semiconductor 13F positioning. Automotive plus industrial cycle dynamics, RF for 5G, plus emerging silicon carbide drive distinctive institutional patterns.
Memory Semi 13Fs: Micron, Western Digital, Seagate Decoder
Micron Technology, Western Digital, Seagate Technology, and Samsung Electronics anchor US-traded memory plus storage 13F positioning. DRAM cycle dynamics, NAND flash transitions, HBM AI demand, and emerging Korean competitors drive distinctive institutional patterns.
CDMO 13Fs: Catalent, Lonza, Samsung Biologics, WuXi Decoder
Catalent, Lonza Group, Samsung Biologics, WuXi Biologics, and emerging US contract development plus manufacturing operators anchor specialty CDMO 13F positioning. Biologics manufacturing capacity, GLP-1 production, gene therapy capabilities, and BIOSECURE Act drive distinctive institutional patterns.
Contract Research 13Fs: IQVIA, Icon, Medpace, Charles River
IQVIA Holdings, ICON plc, Medpace Holdings, Charles River Laboratories, and Syneos Health anchor US-traded contract research organization (CRO) 13F positioning. Pharma R&D outsourcing cycles, AI integration, biotech funding dynamics, and emerging trial complexity drive distinctive institutional patterns.
Digital Health 13Fs: Teladoc, Doximity, Amwell, Hims & Hers
Card Network 13Fs: Visa, Mastercard, Fiserv, FIS Decoder
Visa, Mastercard, Fiserv, FIS, and Global Payments anchor US card network plus payment processing 13F positioning. Multi-decade network effects, B2B payments emerging opportunity, cross-border travel demand, and emerging real-time payments competition drive distinctive institutional patterns.
Specialty Minerals 13Fs: Compass, ICL, Albemarle, MP Materials
Shipbuilding 13Fs: Huntington Ingalls, General Dynamics, Mitsui
Huntington Ingalls Industries, General Dynamics (Electric Boat segment), Mitsui OSK Lines, and emerging Korea-listed shipbuilders anchor US-traded shipbuilding 13F positioning. Multi-decade naval contracts, commercial shipbuilding cycles, plus emerging LNG carrier construction drive distinctive institutional patterns.
Education Tech 13Fs: Duolingo, Coursera, Chegg, Stride Decoder
Duolingo, Coursera, Chegg, Stride, and Grand Canyon Education anchor US education technology 13F positioning. Subscription growth dynamics, AI tutoring disruption, regulatory headwinds, and emerging international expansion drive distinctive institutional patterns.
Beer 13Fs: Anheuser-Busch, Molson Coors, Boston Beer Decoder
Anheuser-Busch InBev, Molson Coors Beverage, Boston Beer Company, and emerging Tilray Brands beer business anchor US-traded beer 13F positioning. Multi-decade volume decline, premiumization mix, hard seltzer dynamics, plus emerging non-alcoholic beer drive distinctive institutional patterns.
Spirits 13Fs: Diageo, Constellation, Brown-Forman Decoder
Diageo, Constellation Brands, Brown-Forman, MGP Ingredients, and Monster Beverage anchor US-traded premium spirits plus emerging beverage 13F positioning. Premium-vs-mainstream mix, GLP-1 disruption, tequila plus emerging category dynamics drive distinctive institutional patterns.
Gas Utility 13Fs: Atmos, ONEOK, NiSource, Southwest Gas Decoder
Atmos Energy, ONEOK, NiSource, Southwest Gas Holdings, and Spire anchor US natural gas utility 13F positioning. Regulated rate-base economics, multi-decade dividend growth, AI data center natural gas demand, and emerging hydrogen infrastructure drive distinctive institutional patterns.
LNG 13Fs: Cheniere, Tellurian, NextDecade, Venture Global
Cheniere Energy, Cheniere Energy Partners, NextDecade, Venture Global LNG, and Tellurian anchor US LNG export 13F positioning. Long-term offtake contracts, construction cycle dynamics, European-Asian demand evolution, and emerging US-Russia LNG geopolitics drive distinctive institutional patterns.
Coal Mining 13Fs: Peabody, Arch, Consol, Alpha Decoder
Peabody Energy, Arch Resources, CONSOL Energy, Alpha Metallurgical Resources, and Warrior Met Coal anchor US coal mining 13F positioning. Thermal vs metallurgical coal economics, AI data center power demand, ESG mandate exclusion, and capital return discipline drive distinctive institutional patterns.
Defense Services 13Fs: Leidos, Booz Allen, SAIC, CACI Decoder
Leidos, Booz Allen Hamilton, SAIC, CACI International, and ICF International anchor US defense services 13F positioning. Multi-year DoD contract cycles, AI plus cybersecurity integration, intelligence community spending, and capital allocation drive distinctive institutional patterns.
Aluminum 13Fs: Alcoa, Kaiser, Century, Constellium Decoder
Alcoa, Kaiser Aluminum, Century Aluminum, Constellium, plus Norsk Hydro anchor US-traded aluminum 13F positioning. Bauxite-alumina-aluminum vertical economics, EV body sheet demand, energy cost dynamics, and tariff plus trade policy drive distinctive institutional patterns.
Gene Therapy 13Fs: CRISPR, Intellia, Beam, Editas, Sarepta
CRISPR Therapeutics, Intellia Therapeutics, Beam Therapeutics, Editas Medicine, and Sarepta Therapeutics anchor US gene therapy 13F positioning. Clinical milestone cycles, manufacturing scaling, reimbursement framework development, and ongoing M&A drive distinctive institutional patterns.